Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Michele Fox

Concepts (268)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Mobilization
11
2018
57
1.520
 Why?
Multiple Myeloma
26
2024
2954
1.430
 Why?
Hematopoietic Stem Cell Transplantation
13
2023
567
1.300
 Why?
Hematopoietic Stem Cells
8
2018
184
1.280
 Why?
Blood Platelets
5
2017
249
0.830
 Why?
Antigens, CD34
9
2018
66
0.770
 Why?
Melphalan
4
2016
174
0.580
 Why?
Leukapheresis
3
2018
14
0.580
 Why?
Bone Marrow Transplantation
4
2016
116
0.560
 Why?
Blood Component Removal
4
2018
10
0.560
 Why?
Purpura, Thrombotic Thrombocytopenic
2
2018
15
0.550
 Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
990
0.540
 Why?
Plasma Exchange
3
2015
23
0.510
 Why?
Fetal Blood
3
2023
69
0.460
 Why?
Cell Separation
2
2013
90
0.420
 Why?
Pregnant Women
1
2023
77
0.400
 Why?
Killer Cells, Natural
2
2015
107
0.390
 Why?
Cell Proliferation
5
2018
1013
0.360
 Why?
Immunotherapy, Adoptive
2
2015
157
0.360
 Why?
Transplantation, Autologous
8
2013
469
0.350
 Why?
Myelodysplastic Syndromes
2
2013
81
0.350
 Why?
Granulocyte Colony-Stimulating Factor
4
2012
61
0.350
 Why?
Humans
43
2024
50208
0.350
 Why?
Blood Specimen Collection
1
2019
34
0.330
 Why?
Blood Transfusion
2
2017
126
0.330
 Why?
Thalidomide
4
2016
377
0.320
 Why?
Blood Volume
1
2019
69
0.320
 Why?
Aged
21
2017
9405
0.320
 Why?
Education, Distance
1
2019
40
0.320
 Why?
Adult
22
2019
13324
0.320
 Why?
Clinical Laboratory Techniques
1
2018
30
0.310
 Why?
Obstetrics
1
2019
88
0.300
 Why?
Leukocytes, Mononuclear
1
2018
115
0.300
 Why?
Cyclooxygenase Inhibitors
1
2017
39
0.290
 Why?
Blood Grouping and Crossmatching
1
2017
5
0.290
 Why?
Blood Coagulation
1
2017
56
0.290
 Why?
Chromosome Aberrations
3
2016
297
0.290
 Why?
Middle Aged
21
2018
12206
0.290
 Why?
Flow Cytometry
2
2016
476
0.270
 Why?
Antibodies
1
2016
154
0.270
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
122
0.270
 Why?
Aspirin
1
2017
114
0.270
 Why?
Erythrocyte Transfusion
2
2015
46
0.270
 Why?
Platelet Aggregation Inhibitors
1
2017
174
0.260
 Why?
Female
22
2023
26635
0.250
 Why?
Hemoglobins, Abnormal
1
2015
4
0.250
 Why?
Heparin
1
2015
92
0.250
 Why?
Thrombocytopenia
1
2015
84
0.250
 Why?
Stem Cell Transplantation
2
2013
182
0.240
 Why?
Factor VIII
1
2014
23
0.240
 Why?
ADAM Proteins
1
2014
20
0.240
 Why?
Leukocytes
2
2011
67
0.240
 Why?
Anemia, Sickle Cell
1
2015
96
0.230
 Why?
Male
21
2019
25399
0.220
 Why?
Follow-Up Studies
8
2024
2190
0.220
 Why?
Internship and Residency
1
2019
441
0.220
 Why?
Antiretroviral Therapy, Highly Active
1
2013
34
0.210
 Why?
Leukemia
1
2013
65
0.210
 Why?
Afibrinogenemia
1
2012
5
0.210
 Why?
Neoplasm Recurrence, Local
2
2015
613
0.210
 Why?
Graft Survival
4
2011
150
0.210
 Why?
Prognosis
6
2018
1954
0.200
 Why?
Aldehyde Dehydrogenase
1
2011
26
0.200
 Why?
Transplantation Conditioning
3
2003
84
0.200
 Why?
Boronic Acids
2
2013
182
0.190
 Why?
Pyrazines
2
2013
187
0.190
 Why?
Plateletpheresis
1
2010
7
0.190
 Why?
Blood Preservation
1
2010
26
0.180
 Why?
Retrospective Studies
8
2018
6134
0.180
 Why?
Transplantation, Homologous
5
2016
138
0.180
 Why?
Cryopreservation
1
2010
31
0.180
 Why?
Blood Proteins
1
2010
82
0.180
 Why?
Anaphylaxis
1
2010
71
0.170
 Why?
Chromosomes, Human, Pair 1
2
2007
93
0.170
 Why?
Cell Survival
5
2011
602
0.160
 Why?
Graft vs Host Disease
5
2003
75
0.160
 Why?
HIV Infections
1
2013
357
0.160
 Why?
Receptors, KIR
1
2008
13
0.160
 Why?
Gene Expression Regulation, Neoplastic
2
2016
828
0.160
 Why?
Myeloablative Agonists
1
2007
30
0.150
 Why?
Cell Movement
2
2006
249
0.150
 Why?
Immunosuppressive Agents
2
2014
222
0.150
 Why?
Treatment Outcome
11
2013
5155
0.150
 Why?
Dexamethasone
3
2024
430
0.140
 Why?
Risk Factors
7
2015
3629
0.140
 Why?
Models, Genetic
1
2006
170
0.140
 Why?
Osteogenesis
2
2006
353
0.130
 Why?
Young Adult
4
2019
3981
0.130
 Why?
Models, Statistical
1
2007
224
0.130
 Why?
Combined Modality Therapy
4
2014
636
0.130
 Why?
Macrophages
1
2018
363
0.130
 Why?
Gene Expression Profiling
2
2007
1037
0.130
 Why?
Platelet Count
3
2017
72
0.130
 Why?
Cytokines
2
2006
613
0.130
 Why?
Incidence
3
2017
1006
0.120
 Why?
Enzyme-Linked Immunosorbent Assay
2
2015
244
0.120
 Why?
Time Factors
1
2010
2922
0.120
 Why?
Antineoplastic Agents
3
2012
1186
0.120
 Why?
Pregnancy
2
2023
2604
0.110
 Why?
Cytotoxicity Tests, Immunologic
2
2016
28
0.110
 Why?
Disease-Free Survival
3
2016
454
0.110
 Why?
Blood Banks
1
2023
18
0.110
 Why?
Bone Marrow Cells
1
2004
190
0.110
 Why?
Metaphase
2
2016
44
0.110
 Why?
Bone Diseases
1
2004
99
0.110
 Why?
Osteoblasts
1
2006
450
0.110
 Why?
Cell Count
3
2011
149
0.110
 Why?
Cyclosporine
1
2003
65
0.100
 Why?
Tacrolimus
1
2003
52
0.100
 Why?
Blood Group Incompatibility
1
2002
5
0.100
 Why?
ABO Blood-Group System
1
2002
15
0.100
 Why?
Universities
1
2023
162
0.100
 Why?
Kaplan-Meier Estimate
3
2007
465
0.100
 Why?
Coculture Techniques
3
2018
146
0.100
 Why?
T-Lymphocyte Subsets
1
2001
39
0.090
 Why?
Osteoclasts
1
2004
428
0.090
 Why?
Models, Biological
1
2004
723
0.090
 Why?
T-Lymphocytes, Cytotoxic
1
2010
65
0.090
 Why?
Heart Failure
1
2006
506
0.090
 Why?
Prospective Studies
4
2016
2379
0.090
 Why?
Lung Diseases
1
2001
93
0.090
 Why?
Thrombosis
1
2003
248
0.090
 Why?
Cancer Vaccines
1
2010
78
0.090
 Why?
Dendritic Cells
1
2010
133
0.080
 Why?
Erythroid Precursor Cells
1
2019
15
0.080
 Why?
Birth Weight
1
2019
120
0.080
 Why?
Hematocrit
1
2018
45
0.080
 Why?
Medical Waste
1
2017
2
0.080
 Why?
Cell Aggregation
1
2017
6
0.080
 Why?
Antineoplastic Agents, Alkylating
2
2008
74
0.070
 Why?
Lymphoma
1
2018
66
0.070
 Why?
Arkansas
2
2017
1985
0.070
 Why?
Program Evaluation
1
2019
354
0.070
 Why?
Lymphoma, Follicular
1
2017
27
0.070
 Why?
Histocompatibility Antigens Class I
1
2017
44
0.070
 Why?
Logistic Models
2
2017
889
0.070
 Why?
Adolescent
3
2015
6390
0.070
 Why?
Lung
1
2001
490
0.070
 Why?
Neoplasms
1
2007
1249
0.070
 Why?
Risk
1
2017
324
0.070
 Why?
Fibrosis
1
2017
180
0.070
 Why?
Dose-Response Relationship, Drug
3
2008
1378
0.070
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2017
106
0.070
 Why?
Curriculum
1
2019
400
0.070
 Why?
Recurrence
2
2008
662
0.070
 Why?
Hemorrhage
1
2017
197
0.070
 Why?
Hemoglobin J
1
2015
3
0.060
 Why?
Hemoglobin, Sickle
1
2015
6
0.060
 Why?
Hemoglobin C
1
2015
6
0.060
 Why?
Blood Donors
1
2015
31
0.060
 Why?
Diagnosis, Differential
1
2018
1043
0.060
 Why?
Neoplasm Proteins
1
2016
324
0.060
 Why?
Reproducibility of Results
1
2017
1185
0.060
 Why?
Age Factors
3
2005
1092
0.060
 Why?
Autoantibodies
1
2014
116
0.060
 Why?
Blotting, Western
1
2015
601
0.060
 Why?
CD4 Lymphocyte Count
1
2013
32
0.050
 Why?
Viral Load
1
2013
77
0.050
 Why?
Transplantation Chimera
3
2003
15
0.050
 Why?
Acute Disease
1
2013
368
0.050
 Why?
Benzylamines
1
2012
15
0.050
 Why?
Receptors, CXCR4
1
2012
28
0.050
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2012
56
0.050
 Why?
Heterocyclic Compounds
1
2012
29
0.050
 Why?
Immunohistochemistry
1
2015
978
0.050
 Why?
Infant, Newborn
1
2019
2766
0.050
 Why?
Clinical Protocols
1
2012
108
0.050
 Why?
Immune Tolerance
1
2011
95
0.050
 Why?
Dimethyl Sulfoxide
1
2010
12
0.050
 Why?
Isotonic Solutions
1
2010
18
0.050
 Why?
Platelet Transfusion
1
2010
28
0.050
 Why?
P-Selectin
1
2010
32
0.050
 Why?
Algorithms
2
2005
618
0.050
 Why?
Sodium Chloride
1
2010
58
0.050
 Why?
Platelet Aggregation
1
2010
71
0.050
 Why?
Platelet Activation
1
2010
47
0.040
 Why?
Multivariate Analysis
2
2007
581
0.040
 Why?
Feasibility Studies
1
2011
380
0.040
 Why?
Hypersensitivity
1
2010
77
0.040
 Why?
Haplotypes
1
2008
84
0.040
 Why?
Nitric Oxide Synthase Type II
1
2018
66
0.040
 Why?
Ligands
1
2008
205
0.040
 Why?
Arginase
1
2018
35
0.040
 Why?
Hemoglobins
1
2008
107
0.040
 Why?
Polyethylene Glycols
1
2008
93
0.040
 Why?
Age Distribution
1
2007
168
0.040
 Why?
Cytogenetic Analysis
1
2007
82
0.040
 Why?
Tissue Donors
2
2003
113
0.040
 Why?
Antineoplastic Agents, Hormonal
1
2007
48
0.040
 Why?
Recombinant Proteins
1
2008
487
0.040
 Why?
Multigene Family
1
2006
56
0.040
 Why?
Mice
2
2018
5759
0.030
 Why?
Chromosome Deletion
1
2007
140
0.030
 Why?
Chromosome Mapping
1
2006
156
0.030
 Why?
In Situ Hybridization, Fluorescence
1
2007
259
0.030
 Why?
Angiogenesis Inhibitors
1
2007
188
0.030
 Why?
Leukemia, Myeloid, Acute
1
2007
185
0.030
 Why?
Cell Line
1
2008
1021
0.030
 Why?
Interleukin-10
1
2006
84
0.030
 Why?
Cell Communication
1
2006
69
0.030
 Why?
Neoplasms, Experimental
1
2006
114
0.030
 Why?
Stroke Volume
1
2006
129
0.030
 Why?
Ventricular Dysfunction, Left
1
2006
94
0.030
 Why?
Predictive Value of Tests
1
2007
905
0.030
 Why?
Myocardial Ischemia
1
2006
121
0.030
 Why?
Databases, Factual
1
2007
657
0.030
 Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
30
0.030
 Why?
Bromodeoxyuridine
1
2004
19
0.030
 Why?
Annexin A5
1
2004
13
0.030
 Why?
Mice, Transgenic
1
2006
550
0.030
 Why?
Culture Media, Conditioned
1
2004
48
0.030
 Why?
Phagocytosis
1
2004
49
0.030
 Why?
Survival Rate
1
2006
901
0.030
 Why?
Tumor Necrosis Factor-alpha
1
2006
388
0.030
 Why?
Aged, 80 and over
2
2006
3154
0.030
 Why?
Chronic Disease
1
2006
571
0.030
 Why?
Cell Division
1
2004
295
0.030
 Why?
Plasmapheresis
1
2003
11
0.030
 Why?
RANK Ligand
1
2004
179
0.030
 Why?
Membrane Glycoproteins
1
2004
246
0.030
 Why?
Severity of Illness Index
1
2006
951
0.030
 Why?
Interleukin-6
1
2004
265
0.030
 Why?
Salvage Therapy
2
2003
139
0.030
 Why?
Cohort Studies
1
2006
1422
0.030
 Why?
Child
1
2015
6851
0.030
 Why?
NF-kappa B
1
2004
315
0.030
 Why?
Carrier Proteins
1
2004
306
0.030
 Why?
Red-Cell Aplasia, Pure
1
2002
7
0.030
 Why?
Animals
2
2018
13246
0.020
 Why?
Antigens, CD
1
2003
221
0.020
 Why?
Survival Analysis
2
2003
666
0.020
 Why?
Gene Rearrangement, T-Lymphocyte
1
2001
2
0.020
 Why?
Lymphocyte Count
1
2001
22
0.020
 Why?
Cell Differentiation
1
2004
650
0.020
 Why?
Bronchoalveolar Lavage Fluid
1
2001
40
0.020
 Why?
Clone Cells
1
2001
78
0.020
 Why?
Graft Rejection
1
2002
168
0.020
 Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
 Why?
CD40 Ligand
1
2010
14
0.020
 Why?
Hypersensitivity, Delayed
1
2010
21
0.020
 Why?
Disease Models, Animal
1
2006
1458
0.020
 Why?
Interleukin-4
1
2010
43
0.020
 Why?
Adjuvants, Immunologic
1
2010
51
0.020
 Why?
Immunity, Cellular
1
2010
70
0.020
 Why?
Magnetic Resonance Imaging
1
2007
1541
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2001
128
0.020
 Why?
Interferon-gamma
1
2010
176
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2001
595
0.020
 Why?
Transcription, Genetic
1
2001
369
0.020
 Why?
B-Lymphocytes
1
2010
170
0.020
 Why?
CD4-Positive T-Lymphocytes
1
2001
164
0.020
 Why?
Vaccination
1
2010
271
0.020
 Why?
Stem Cell Factor
1
2003
7
0.010
 Why?
Confidence Intervals
1
2003
156
0.010
 Why?
Lymphocyte Transfusion
1
2003
10
0.010
 Why?
Probability
1
2003
164
0.010
 Why?
Leukocyte Count
1
2003
72
0.010
 Why?
Infusions, Intravenous
1
2003
213
0.010
 Why?
Cyclophosphamide
1
2003
166
0.010
 Why?
Drug Administration Schedule
1
2003
377
0.010
 Why?
Remission Induction
1
2003
207
0.010
 Why?
Administration, Oral
1
2003
434
0.010
 Why?
Neutrophils
1
2003
148
0.010
 Why?
Doxorubicin
1
2003
239
0.010
 Why?
Cisplatin
1
2003
278
0.010
 Why?
Neoplasm Staging
1
2003
738
0.010
 Why?
Drug Resistance, Neoplasm
1
2003
314
0.010
 Why?
Disease Progression
1
2003
831
0.010
 Why?
Fox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (268) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department